Aigen Investment Management, LP Regenxbio Inc. Transaction History

Aigen Investment Management, LP

  • $487 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 11, 2021
SELL
$33.61 - $49.95 $302,422 - $449,450
-8,998 Closed
0 $0
Q4 2020

Feb 12, 2021
SELL
$26.52 - $49.35 $976,042 - $1.82 Million
-36,804 Reduced 80.35%
8,998 $408,000
Q3 2020

Nov 06, 2020
BUY
$27.01 - $40.26 $995,669 - $1.48 Million
36,863 Added 412.38%
45,802 $1.26 Million
Q2 2020

Aug 10, 2020
BUY
$27.75 - $43.44 $248,057 - $388,310
8,939 New
8,939 $329,000

Others Institutions Holding RGNX

# of Institutions
197
Shares Held
43.2M
Call Options Held
104K
Put Options Held
478K
View Full List

About REGENXBIO Inc.

RGNX Quotes by TradingView
  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $433M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Aigen Investment Management, LP Portfolio

Follow Aigen Investment Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Aigen Investment Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email